Market Place
Sourcing Support
Fortress, Urica Dose First Patients In Ph3 Dotinurad Gout Trial
21 Oct 2025 //
GLOBENEWSWIRE
Crystalys Therapeutics Progresses Dotinurad Phase 3 Trials
21 Oct 2025 //
PR NEWSWIRE
Fortress Biotech And Urica Therapeutics Unveil Crystalys
01 Oct 2025 //
GLOBENEWSWIRE
Revarazan Hcl For Acute Gastritis, Chronic Gastritis Gastric Mucosal Lesions
28 Mar 2024 //
PRESS RELEASE
Urica Announces Topline Data from the Ph1 Trial Evaluating Dotinurad
29 Jun 2023 //
GLOBENEWSWIRE
Urica Therapeutics Expands Exclusive License Agreement with Fuji Yakuhin
14 Dec 2022 //
GLOBENEWSWIRE
Fortress Biotech Announces First Patient Dosed in PI Trial of Dotinurad
31 May 2022 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.